Andrea Canturri-Miro
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections.
Journal: Frontiers in microbiology
Published: December 28, 2021
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Journal: Microbiology spectrum
Published: October 20, 2021
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 05, 2021
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.
Journal: Antibiotics (Basel, Switzerland)
Published: March 10, 2021
Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models.
Journal: Antibiotics (Basel, Switzerland)
Published: January 18, 2021
Repositioning rafoxanide to treat Gram-negative bacilli infections.
Journal: The Journal of antimicrobial chemotherapy
Published: December 12, 2019
Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria.
Journal: Antibiotics (Basel, Switzerland)
Published: December 05, 2019
Role of PstS in the Pathogenesis of Acinetobacter baumannii Under Microaerobiosis and Normoxia.
Journal: The Journal of infectious diseases
Published: September 12, 2019
The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
Journal: International journal of antimicrobial agents
Published: April 18, 2019
Drug Repurposing for the Treatment of Bacterial and Fungal Infections.
Journal: Frontiers in microbiology
Published: October 02, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026